Attributing to the anti‐inflammatory, antioxidative and immunoregulatory activities, TGP has achieved remarkable efficacy and good tolerance in these inflammatory diseases, whereas, its application in BD patients has not been reported [11]. The gene discussed is TGM4; the disease is Behcet disease.